This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
This guide compares risk profiles of index funds and bonds in retirement, helping you choose allocations that align with your comfort and goals.
28,591 articlesBiotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
Silver sank sharply as the Federal Reserve signaled no quick rate cuts, fueling a silver price prediction: lost debat...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
Got $1,000 to invest? This article outlines a real-world plan, explains why Nvidia makes sense before Micron, and giv...
Nike has fallen 32% from its pandemic peak, boosting its dividend yield. This article weighs the dividend health, gro...
Prediction markets pricing pennies on a Bitcoin 150K scenario sound far-fetched—until you unpack how odds, liquidity,...
Think saving $10,000 in one year is impossible? This banking-focused blueprint shows how to automate, cut costs, and ...
Micron sits at the crossroads of AI demand, data-center spending, and cyclical memory trends. This guide explains why...
Eight years in stealth have shaped a new robotics venture from Travis Kalanick, with implications for workers, equity...
Investors can gain exposure to Bill Ackman’s top stocks without buying Pershing Square. A trio of ETFs offers a cost-...
Solana is trading in a narrow band as a key indicator points to a potential breakout. Analysts caution that volatilit...